About this template
The Industry — Biotech template is a clinical CV set in Manrope and Inter on mint paper, with a deep violet accent and JetBrains Mono micro-labels. Dedicated sections for publications, patents, clinical-trial phases and laboratory platforms organise the read around the metrics biotech and pharma recruiters actually scan first.
Who is it for?
It suits PhDs in life sciences, R&D leads, clinical operations and regulatory-affairs profiles applying to Moderna, BioNTech, Pfizer R&D, Genentech, Amgen, Regeneron, Vertex, Illumina, Ginkgo Bioworks and the European CROs (ICON, IQVIA, Parexel, Syneos). Equally fit for translational-medicine researchers and bioprocess engineers in university spin-offs preparing Series A or B fundraising decks.
How to use it
Structure roles around therapeutic area (oncology, immunology, rare disease, neurology, cardiometabolic), phase (preclinical, Phase I, IIa, IIb, III, IV) and pipeline metrics (validated target, lead optimisation, IND filed, NDA submitted). Cite publications by Scimago quartile rather than impact factor for stable cross-jurisdiction reading. Always name the GxP standards mastered (GLP, GCP, GMP, GVP) and FDA, EMA or MHRA submissions you contributed to with your exact role.
Frequently asked questions
How should patents appear on a biotech CV?
Always distinguish legal status. Granted patent: full number (e.g. US10987654 B2, EP3456789 B1) and jurisdiction. Pending application: publication number followed by A1 and 'pending examination'. State your inventor position (first, co-inventor). Everything is checkable on USPTO Patent Center, Espacenet and WIPO PatentScope, so any inflation is immediately visible.
Should I list impact factor or quartile?
For US, UK and Swiss biotech employers (Genentech, Vertex, Roche, Novartis), Scimago quartile (Q1, Q2) is preferred — it is less manipulable than impact factor and survives editorial changes. For European applications (France, Italy, Spain), list both in parentheses to cover the audience range. Avoid h-index inflation tactics — top biotech recruiters know them all.
How do I list a multi-sponsor CRO history?
List studies by phase and therapeutic area without naming NDA-bound sponsors. 'Phase IIb solid-tumour oncology, n=240 patients, 18 European sites, 36-month duration' is more readable and more credible than 'Top-10 pharmaceutical sponsor'. Clinical operations directors decode the format and reward operational precision over name-dropping.
